Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

High sexually transmitted infection rates spur condom debate

High sexually transmitted infection rates spur condom debate

, by Liz Highleyman

What’s causing the rising STI rates? And, do rising STI rates mean that we should be promoting condom use for everyone? Read More

For people with drug resistant HIV, monoclonal antibody shows promise as “rescue” therapy

For people with drug resistant HIV, monoclonal antibody shows promise as “rescue” therapy

, by Liz Highleyman

A monoclonal antibody shows promise for people living with HIV who are “left behind,” with few HIV treatment options, when current antiretrovirals fail from drug resistance. Read More

Can a Two-Drug Treatment Regimen Keep HIV Under Control?

Can a Two-Drug Treatment Regimen Keep HIV Under Control?

, by Liz Highleyman

HIV therapy with two drugs, instead of three, kept 90% of people undetectable in a small proof-of-concept study. Read More

AIDS 2016: Undetectable with long-acting, user-friendly injectable HIV medications

AIDS 2016: Undetectable with long-acting, user-friendly injectable HIV medications

, by Liz Highleyman

More than 90% of people receiving a long-acting injection of cabotegravir and rilpivirine maintained an undetectable HIV viral load. Read More

HIV Treatment Plus PrEP Virtually Eliminates HIV Transmission

HIV Treatment Plus PrEP Virtually Eliminates HIV Transmission

, by Liz Highleyman

HIV risk was reduced by 95% for people in serodiscordant relationships with PrEP and TasP, results of the Partners PrEP study show. Read More